Biosimilar medicines used for cancer therapy in Europe: a review

Drug Discovery Today
Sofia B SantosAna C Silva

Abstract

This article provides an updated review of the biosimilar medicines approved for cancer therapy in the European Union (EU). First we discuss the most relevant aspects for the development and approval of biosimilar medicines. We then present the oncological biosimilar drugs currently used, which include epoetins (alpha and zeta), filgrastim, and monoclonal antibodies (rituximab, trastuzumab and bevacizumab). Among the clinical applications of biosimilar medicines, cancer therapy remains the main target area and more approved biosimilars are expected over the next few years, providing cost-effective drugs to more patients. Furthermore, comprehensive pharmacovigilance studies are going on, monitoring the marketed biosimilars, and providing more feasible information to clinicians regarding the safety and efficacy of these medications.

Citations

Mar 5, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Iga PawłowskaIvan Kocić
Aug 31, 2018·The International Journal of Pharmacy Practice·Mohammed I AladulStephen R Chapman
Oct 26, 2018·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·I TakácsI Aradi
Apr 5, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Evelien MoorkensIsabelle Huys
Apr 5, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Evelien MoorkensIsabelle Huys
Jul 4, 2020·Future Oncology·Cornelius F Waller, Adriano Friganović
Dec 5, 2019·Therapeutic Advances in Medical Oncology·Emily M Miller, Lee S Schwartzberg
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ewa Jaszczak-WilkePiotr Bałczewski
May 7, 2021·Frontiers in Pharmacology·Yannick VandenplasIsabelle Huys
May 16, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·José Cleberson Santos SoaresJuliana Lúcia de Albuquerque Vasconcelos
Jun 15, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Aayushi S DitaniRakesh K Tekade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Iain C Macdougall
Expert Opinion on Biological Therapy
Nicole CasadevallDavid G Warnock
Journal of Oncology Practice
Robert M Rifkin, Susan R Peck
© 2022 Meta ULC. All rights reserved